- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.03. | Amgen/Kyowa Kirin share promising phase 3 results for rocatinlimab in atopic dermatitis | ||
| 11.03. | Novartis gains rights to Kyorin's chronic spontaneous urticaria candidate in deal worth $830m | ||
| 11.03. | Vertex's triple combination cystic fibrosis therapy Alyftrek approved by MHRA | ||
| 11.03. | J&J/Protagonist's icotrokinra shows promise in phase 3 plaque psoriasis programme | ||
| 10.03. | Organon shares positive long-term results for Vtama cream in atopic dermatitis | ||
| 10.03. | FDA approves Celltrion's denosumab biosimilars Stoboclo and Osenvelt | ||
| 10.03. | Preparing biotechs for spin-out and beyond | ||
| 10.03. | BMS granted EC approval for immunotherapy combination in liver cancer | ||
| 07.03. | J&J's Lazcluze/Rybrevant combination granted MHRA approval for lung cancer | ||
| 07.03. | AstraZeneca announces promising late-stage results for Imfinzi in gastric cancer | ||
| 07.03. | Takeda/Protagonist share positive phase 3 results for rusfertide in rare blood cancer | ||
| 07.03. | What is it all for? | ||
| 06.03. | Novo Nordisk and Gensaic enter cardiometabolic disease partnership worth $354m | ||
| 06.03. | Eli Lilly's Jaypirca recommended by CHMP to treat chronic lymphocytic leukaemia | ||
| 06.03. | Regeneron receives positive CHMP opinion for linvoseltamab in multiple myeloma | ||
| 06.03. | Healthcare communications | ||
| 05.03. | Moderna's RSV vaccine mRESVIA granted MHRA approval to protect older adults | ||
| 05.03. | Roche's Genentech granted FDA approval for TNKase in acute ischaemic stroke | ||
| 05.03. | BeiGene's Tevimbra approved by FDA for first-line oesophageal cancer use | ||
| 05.03. | Luto expands to Switzerland with new office | ||
| 05.03. | Setting your sights - the marketing objectives that guide everything that follows | ||
| 04.03. | J&J receives three CHMP recommendations for immunology and oncology indications | ||
| 04.03. | Sobi receives NICE recommendation for Altuvoct in severe haemophilia A | ||
| 04.03. | MHRA approves Galderma's Nemluvio to treat atopic dermatitis and prurigo nodularis | ||
| 04.03. | The full potential of patient journeys in pharma |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
